▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1299 by analyst upside · 2026-11-12
OMDA
Omada Health, Inc.
Healthcare · Market Cap $945M · P/E 38.1x
ANALYST PRICE TARGET
+76.6%
implied upside to consensus target
Current Price $15.24
Consensus Target $26.92
Bull Target $35.0
Bear Target $19.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
5
Hold
2
Sell
0
52-Week Low $10.28
52-Week High $25.45
YTD Return +2.3%
FUNDAMENTALS
Market Cap $945M
P/E Ratio (TTM) 38.1x
Forward P/E 22.9x
EPS (TTM) $0.40
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $333M
Profit Margin 4.2%
52-WEEK RANGE
52-Week Low $10.28
52-Week High $25.45
Current Price $15.24
Bear Target $19.0
Bull Target $35.0
● Now $15.24 ● Target $26.92
TRADING DATA
Avg Volume 1.3M
YTD Return +2.3%
Analyst Count 12
Consensus Buy
Upside to Target +76.6%
Last Updated 2026-11-12

ANALYST SUMMARY

Omada Health, Inc. (OMDA) is currently trading at $15.24 with a Wall Street consensus price target of $26.92, implying potential upside of 76.6% over the next 12 months. 12 analysts currently cover OMDA, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $19.0.

OMDA operates in the Healthcare sector with a market capitalisation of $945M. The stock is up 2.3% year-to-date and is currently trading near the lower end of its 52-week range of $10.28 – $25.45.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OMDA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-11-06 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-11-06 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-28 Building track record
Freedom Capital Markets - Reiterated
Buy → Buy 2026-10-14 Building track record
Freedom Capital Markets - Reiterated
Buy → Buy 2026-09-14 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-09-11 Building track record
Needham reit
Buy → Buy 2026-09-11 20% win rate (5 calls)
BTIG reit
Buy → Buy 2026-09-11 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
20/30
Consensus clarity
9/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →